Literature DB >> 8627810

Serum- and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16.

L Sherman1, R Schlegel.   

Abstract

Transfection of the E6 and E7 genes of the high-risk human papillomaviruses (HPVs) into primary genital keratinocytes generates colonies of proliferating cells which are resistant to calcium- and serum-induced terminal differentiation. To genetically map the HPV gene(s) responsible for this cellular phenotype, we cloned cDNAs for full-length E6, full-length E7, four truncated E6 splice variants (E6I to E6IV), and a series of E6 C-terminal truncation mutants into a simian virus 40 expression vector. The E6 proteins were tagged with the AU1 epitope at the C terminus to verify their expression in COS cells by immunoprecipitation and immunofluorescence. Transfection of the full-length E6 protein, either wild type or epitope tagged, induced calcium- and serum-resistant keratinocyte colonies, but the truncated E6 variants and full-length E7 protein did not. E6-induced colonies, while altered in response to serum and calcium, could not be established into cell lines without the combined presence of the E7 protein, further exemplifying the independent roles of E6 and E7 in cell differentiation and cell proliferation. The E6 C-terminal deletion mutants defined two distinct functional domains between amino acids 120 and 151. Amino acids 120 to 151 contained an apparent bipartite nuclear localization signal, whereas amino acids 132 to 141 were required for the induction of resistance to calcium- and serum-induced differentiation and for immortalization of human keratinocytes in conjunction with E7.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627810      PMCID: PMC190193     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

Authors:  J Momand; G P Zambetti; D C Olson; D George; A J Levine
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

Review 2.  Nuclear targeting sequences--a consensus?

Authors:  C Dingwall; R A Laskey
Journal:  Trends Biochem Sci       Date:  1991-12       Impact factor: 13.807

3.  Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16.

Authors:  C Desaintes; S Hallez; P Van Alphen; A Burny
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

4.  The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A.

Authors:  W C Phelps; C L Yee; K Münger; P M Howley
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

5.  Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity.

Authors:  S A Sedman; N L Hubbert; W C Vass; D R Lowy; J T Schiller
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

6.  Recombinant retroviruses encoding human papillomavirus type 18 E6 and E7 genes stimulate proliferation and delay differentiation of human keratinocytes early after infection.

Authors:  C D Woodworth; S Cheng; S Simpson; L Hamacher; L T Chow; T R Broker; J A DiPaolo
Journal:  Oncogene       Date:  1992-04       Impact factor: 9.867

7.  The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells.

Authors:  C L Halbert; G W Demers; D A Galloway
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

8.  Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein.

Authors:  J J Chen; C E Reid; V Band; E J Androphy
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

9.  A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18.

Authors:  J M Huibregtse; M Scheffner; P M Howley
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

10.  Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription.

Authors:  M S Lechner; D H Mack; A B Finicle; T Crook; K H Vousden; L A Laimins
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

View more
  28 in total

1.  Change of the death pathway in senescent human fibroblasts in response to DNA damage is caused by an inability to stabilize p53.

Authors:  A Seluanov; V Gorbunova; A Falcovitz; A Sigal; M Milyavsky; I Zurer; G Shohat; N Goldfinger; V Rotter
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

2.  Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase.

Authors:  S Nakagawa; J M Huibregtse
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

Review 3.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

Review 4.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

5.  HPV E7 contributes to the telomerase activity of immortalized and tumorigenic cells and augments E6-induced hTERT promoter function.

Authors:  Xuefeng Liu; Jeffrey Roberts; Aleksandra Dakic; Yiyu Zhang; Richard Schlegel
Journal:  Virology       Date:  2008-03-26       Impact factor: 3.616

6.  Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein.

Authors:  K Butz; C Denk; A Ullmann; M Scheffner; F Hoppe-Seyler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

7.  Isolation and characterization of a novel epithelium-specific transcription factor, ESE-1, a member of the ets family.

Authors:  P Oettgen; R M Alani; M A Barcinski; L Brown; Y Akbarali; J Boltax; C Kunsch; K Munger; T A Libermann
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

8.  Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis.

Authors:  Ingeborg Zehbe; Christina Richard; Correne A DeCarlo; Anny Shai; Paul F Lambert; Hava Lichtig; Massimo Tommasino; Levana Sherman
Journal:  Virology       Date:  2008-11-04       Impact factor: 3.616

9.  Gene expression profile of cervical and skin tissues from human papillomavirus type 16 E6 transgenic mice.

Authors:  D Mendoza-Villanueva; J Diaz-Chavez; L Uribe-Figueroa; C Rangel-Escareão; A Hidalgo-Miranda; S March-Mifsut; G Jimenez-Sanchez; Pf Lambert; P Gariglio
Journal:  BMC Cancer       Date:  2008-11-26       Impact factor: 4.430

10.  Large-scale analysis of protein expression changes in human keratinocytes immortalized by human papilloma virus type 16 E6 and E7 oncogenes.

Authors:  Mark A Merkley; Ellen Hildebrandt; Robert H Podolsky; Hilal Arnouk; Daron G Ferris; William S Dynan; Hubert Stöppler
Journal:  Proteome Sci       Date:  2009-08-23       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.